Tumor Microenvironment‐Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade-Reference-Cited by-全球学者库

Tumor Microenvironment‐Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade

Published:2019-02-14 Issue:14 Volume:31 Page:1805888
ISSN:0935-9648
Container-title:Advanced Materials
language:en
Short-container-title:Adv. Mater.

Author:

Zhou Fangyuan¹²,Feng Bing¹³,Yu Haijun¹,Wang Dangge¹³,Wang Tingting¹³,Ma Yuting⁴⁵,Wang Siling²,Li Yaping¹^ORCID

Affiliation:

1. State Key Laboratory of Drug Research and Center of PharmaceuticsShanghai Institute of Materia MedicaChinese Academy of Sciences (CAS) Shanghai 201203 China

2. School of PharmacyShenyang Pharmaceutical University Shenyang 110016 China

3. Chinese Academy of Sciences (UCAS) Beijing 100049 China

4. Center for Systems MedicineInstitute of Basic Medical SciencesChinese Academy of Medical Sciences and Peking Union Medical College 100005 Beijing China

5. Suzhou Institute of Systems Medicine Suzhou 215123 Jiangsu China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adma.201805888

Reference43 articles.

1. Cancer immunotherapy comes of age